Chemoinformaics analysis of ROBUSTAFLAVONE
Molecular Weight | 538.464 | nRot | 3 |
Heavy Atom Molecular Weight | 520.32 | nRig | 36 |
Exact Molecular Weight | 538.09 | nRing | 6 |
Solubility: LogS | -4.004 | nHRing | 2 |
Solubility: LogP | 6.077 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 6 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 4 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 32 |
No. of Oxygen atom | 10 | No. of Arom Bond | 34 |
nHA | 10 | APOL | 70.1223 |
nHD | 6 | BPOL | 23.2657 |
QED | 0.177 |
Synth | 3.034 |
Natural Product Likeliness | 1.184 |
NR-PPAR-gamma | 0.983 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.021 |
Pgp-sub | 0.02 |
HIA | 0.565 |
CACO-2 | -5.259 |
MDCK | 0.00000816 |
BBB | 0.001 |
PPB | 0.987945 |
VDSS | 0.463 |
FU | 0.0402796 |
CYP1A2-inh | 0.895 |
CYP1A2-sub | 0.101 |
CYP2c19-inh | 0.642 |
CYP2c19-sub | 0.034 |
CYP2c9-inh | 0.554 |
CYP2c9-sub | 0.879 |
CYP2d6-inh | 0.161 |
CYP2d6-sub | 0.462 |
CYP3a4-inh | 0.236 |
CYP3a4-sub | 0.057 |
CL | 2.862 |
T12 | 0.521 |
hERG | 0.164 |
Ames | 0.191 |
ROA | 0.031 |
SkinSen | 0.922 |
Carcinogencity | 0.037 |
EI | 0.908 |
Respiratory | 0.035 |
NR-Aromatase | 0.975 |
Antiviral | Yes |
Prediction | 0.67645 |